The activity of sisomicin, gentamicin, and tobramycin against 273 clinical bacterial isolates was about equal (except for greater activity of tobramycin against Pseudomonas) and was greater than that of BB-K 8 as determined by antibiotic dilution methods in agar and broth.
No takes yet. Share an insight, caveat, or question.
Levison et al. (1974) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: